VITARKA THERAPEUTICS LTD
Company number 13291464 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£872,553
Balance sheet as at 2023-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-03-25
- Registered office
- Innovation House Innovation Way, Discovery Park, Sandwich, England, CT13 9FF
- Postcode
- CT13 9FF
- Capital
- 141 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-03-24
- Next due by
- 2027-04-07
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 1 resigned
John William, Dr BEADLE
Director
James Duncan Bruce, Dr FAULKNER
Director
Mayer SCHREIBER
Director
Vineeta, Dr TRIPATHI
Director
Contact details
- Website
- vitarka.co.uk
- Phone
- 0000000000000, 0022204460492, 0090560913085
Vitarka Therapeutics has engineered an intracellular drug delivery technology, EndoPore, using pore forming proteins for intracellular targets.
Among its peers
Top 25%
by shareholders' funds, of 30 similar companies in CT
Trading since 2021.
No.5 of the largest research and experimental development on biotechnology companies in Canterbury →
Competitors Canterbury
This company ranks 5 among research and experimental development on biotechnology in Canterbury.